{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:54:53Z","timestamp":1774666493619,"version":"3.50.1"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"am","delay-in-days":322,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX002774"],"award-info":[{"award-number":["I01 BX002774"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004500"],"award-info":[{"award-number":["I01 BX004500"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6 BX005714"],"award-info":[{"award-number":["IK6 BX005714"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AG050518"],"award-info":[{"award-number":["R01 AG050518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bbr.2023.114497","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T03:50:32Z","timestamp":1684209032000},"page":"114497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Dual orexin\/hypocretin receptor antagonism attenuates NMDA receptor hypofunction-induced attentional impairments in a rat model of schizophrenia"],"prefix":"10.1016","volume":"450","author":[{"given":"Eden B.","family":"Maness","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua A.","family":"Burk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbr.2023.114497_bib1","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"issue":"5328","key":"10.1016\/j.bbr.2023.114497_bib2","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.277.5328.953","article-title":"Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine","volume":"277","author":"Jentsch","year":"1997","journal-title":"Science"},{"issue":"8069","key":"10.1016\/j.bbr.2023.114497_bib3","first-page":"845","article-title":"Mechanism of the antipsychotic effect in the treatment of acute schizophrenia","volume":"1","author":"Johnstone","year":"1978","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.bbr.2023.114497_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"Lieberman","year":"2004","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/brcg.1998.1035","article-title":"Cortical acetylcholine reality distortion schizophrenia and lewy body dementia: too much or too little cortical acetylcholine","volume":"38","author":"Sarter","year":"1998","journal-title":"Brain Cogn."},{"key":"10.1016\/j.bbr.2023.114497_bib8","series-title":"Stahl's Essential Psychopharmacology","author":"Stahl","year":"2008"},{"issue":"Suppl 3","key":"10.1016\/j.bbr.2023.114497_bib9","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00004850-199803003-00004","article-title":"The role of negative symptoms and cognitive dysfunction in schizophrenia outcome","volume":"13","author":"Tamminga","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2023.114497_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4088\/JCP.10075su1.01","article-title":"Antipsychotics in the treatment of schizophrenia: an overview","volume":"72","author":"Tandon","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2045125317737003","article-title":"When the drugs don\u2019t work: treatment-resistant schizophrenia serotonin and serendipity","volume":"8","author":"Lowe","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.bbr.2023.114497_bib13","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.biopsych.2006.10.031","article-title":"Antipsychotic drugs exacerbate impairment on a working memory task in first-episode Schizophrenia","volume":"62","author":"Reilly","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"9690","key":"10.1016\/j.bbr.2023.114497_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1073858413514136","article-title":"Bottom-Up and top-down attention: different processes and overlapping neural systems","volume":"20","author":"Katsuki","year":"2014","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-0173(01)00044-3","article-title":"The cognitive neuroscience of sustained attention: where top-down meets bottom-up","volume":"35","author":"Sarter","year":"2001","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0306-4522(99)00312-7","article-title":"Visual attention task performance in Wistar and Lister Hooded rats: response inhibition deficits after medial prefrontal cortex lesions","volume":"94","author":"Broersen","year":"1999","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/brcg.1996.0010","article-title":"Divided and focused attention in patients with lesion of the prefrontal cortex","volume":"30","author":"Godefroy","year":"1996","journal-title":"Brain Cogn."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/026988119701100210","article-title":"Effects of ibotenic acid-induced loss of neurons in the medial prefrontal cortex of rats on behavioral vigilance: evidence for executive dysfunction","volume":"11","author":"Miner","year":"1997","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib21","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/schbul\/sbs010","article-title":"NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in Schizophrenia","volume":"38","author":"Gonzalez-Burgos","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/appi.ajp.161.3.490","article-title":"Prefrontal broadband noise working memory and genetic risk for Schizophrenia","volume":"161","author":"Winterer","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1388-2457(99)00322-3","article-title":"Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing","volume":"111","author":"Winterer","year":"2000","journal-title":"Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of Schizophrenia: version III-the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of Schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2023.114497_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0891-0618(01)00101-6","article-title":"Cholinergic systems and schizophrenia: primary pathology or epiphenomena","volume":"22","author":"Hyde","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.bbr.2023.114497_bib27","first-page":"327","article-title":"Attention and the Cholinergic System: Relevance to Schizophrenia","volume":"Vol. 28","author":"Lustig","year":"2015"},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib28","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.neuropharm.2010.12.001","article-title":"Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments","volume":"62","author":"Sarter","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114497_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neubiorev.2020.07.038","article-title":"The role of norepinephrine in the pathophysiology of schizophrenia","volume":"118","author":"M\u00e4ki-Marttunen","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2023.114497_bib30","first-page":"2","article-title":"Role of Thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity","author":"Kiss","year":"2011","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114497_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.physbeh.2014.04.038","article-title":"NMDA receptor hypofunction and the thalamus in schizophrenia","volume":"131","author":"Vukadinovic","year":"2014","journal-title":"Physiol. Behav."},{"issue":"23","key":"10.1016\/j.bbr.2023.114497_bib32","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0006-8993(99)01824-7","article-title":"Food intake elicited by central administration of orexins\/hypocretins: identification of hypothalamic sites of action","volume":"842","author":"Dube","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib35","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/pr.109.001321","article-title":"Orexin\/hypocretin: a neuropeptide at the interface of sleep energy homeostasis and reward system","volume":"61","author":"Tsujino","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbr.2023.114497_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2018.08.008","article-title":"Neuropharmacology of attention","volume":"835","author":"Burk","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114497_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2009.08.046","article-title":"Orexin\/hypocretin modulation of the basal forebrain cholinergic system: role in attention","volume":"1314","author":"Fadel","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.2009.02036.x","article-title":"Activation of the basal forebrain by the orexin\/hypocretin neurones","volume":"198","author":"Arrigoni","year":"2010","journal-title":"Acta Physiol."},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1748-1716.2009.02015.x","article-title":"Orexins\/hypocretins and aminergic systems","volume":"198","author":"Eriksson","year":"2010","journal-title":"Acta Physioliga"},{"issue":"10","key":"10.1016\/j.bbr.2023.114497_bib40","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nn.3810","article-title":"Motivational activation: a unifying hypothesis of orexin\/hypocretin function","volume":"17","author":"Mahler","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2004.05.012","article-title":"Orexins\/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic gabaergic noradrenergic and cholinergic signaling","volume":"127","author":"Selbach","year":"2004","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.bbr.2023.114497_bib42","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.biopsych.2004.02.008","article-title":"Modafinil improves cognition and response inhibition in adult attention-deficit\/hyperactivity disorder","volume":"55","author":"Turner","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-015-4139-z","article-title":"Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons","volume":"233","author":"Zajo","year":"2015","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.conb.2013.04.008","article-title":"Control of arousal by the orexin neurons","volume":"23","author":"Alexandre","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbr.2023.114497_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fnagi.2019.00362","article-title":"Effects of intranasal Orexin-A (Hypocretin-1) administration on neuronal activation, neurochemistry and attention in aged rats","volume":"11","author":"Calva","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00000542-200605000-00019","article-title":"Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane Anesthesia","volume":"104","author":"Dong","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbr.2023.114497_bib47","article-title":"Plasma Orexin-A levels in patients with schizophrenia: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114497_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2014.12.012","article-title":"Elevated plasma orexin A levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms","volume":"53","author":"Chien","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"15","key":"10.1016\/j.bbr.2023.114497_bib49","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1523\/JNEUROSCI.22-15-06742.2002","article-title":"Differential activation of Orexin Neurons by Antipsychotic drugs associated with weight gain","volume":"22","author":"Fadel","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2023.114497_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.815456","article-title":"Understanding the effects of antipsychotics on appetite control","volume":"8","author":"Mukherjee","year":"2022","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41398-021-01235-8","article-title":"Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis","volume":"11","author":"Elam","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/ijnp\/pyaa080","article-title":"Orexin modulation of VTA dopamine neuron activity: relevance to schizophrenia","volume":"24","author":"Perez","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.bbr.2023.114497_bib53","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/schbul\/sbm096","article-title":"The Orexins\/Hypocretins and Schizophrenia","volume":"33","author":"Deutch","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbr.2023.114497_bib54","first-page":"11","article-title":"Interaction between Orexin Neurons and Monoaminergic Systems","volume":"Vol. 45","author":"Sakurai","year":"2021"},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12031-011-9526-2","article-title":"Orexins\/Hypocretins acting at Gi Protein-Coupled OX2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures","volume":"46","author":"Urba\u0144ska","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib56","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.neuropharm.2011.10.003","article-title":"Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomnia","volume":"62","author":"Winrow","year":"2012","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.44","article-title":"Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801","volume":"6","author":"Bygrave","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbr.2023.114497_bib58","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1017\/S146114570900042X","article-title":"Dizocilpine (MK-801) induces distinct changes of N-methyl-d-aspartic acid receptor subunits in parvalbumin-containing interneurons in young adult rat prefrontal cortex","volume":"12","author":"Xi","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biopsych.2010.03.004","article-title":"Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia","volume":"68","author":"Amitai","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"4\u20136","key":"10.1016\/j.bbr.2023.114497_bib60","first-page":"365","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol. Neurobiol."},{"issue":"1\u20133","key":"10.1016\/j.bbr.2023.114497_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2007.08.037","article-title":"Dizocilpine-induced accuracy deficits in a visual signal detection task are not present following D-cycloserine administration in rats","volume":"577","author":"Howe","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hipo.20367","article-title":"A single application of MK801 causes symptoms of acute psychosis deficits in spatial memory and impairments of synaptic plasticity in rats","volume":"18","author":"Manahan-Vaughan","year":"2007","journal-title":"Hippocampus"},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib63","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuropharm.2009.01.004","article-title":"Effects of antipsychotic drugs on MK-801-induced attention and motivational deficits in rats","volume":"56","author":"Paine","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2023.114497_bib64","series-title":"Methods of Behavior Analysis in Neuroscience","article-title":"Assessing Attention in Rodents","author":"Bushnell","year":"2009"},{"issue":"8","key":"10.1016\/j.bbr.2023.114497_bib65","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.euroneuro.2014.04.007","article-title":"The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats","volume":"24","author":"Nikiforuk","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib66","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-011-2277-5","article-title":"A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory","volume":"217","author":"Smith","year":"2011","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-007-0808-x","article-title":"Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","volume":"193","author":"Amitai","year":"2007","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(02)00292-0","article-title":"Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention","volume":"114","author":"Arnold","year":"2002","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/BF02246109","article-title":"Behavioral vigilance in rats: task validation and effects of age amphetamine and benzodiazepine receptor ligands","volume":"117","author":"McGaughy","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2023.114497_bib70","series-title":"The Orexin\/Hypocretin System","first-page":"99","article-title":"Hypocretin Receptor 1 Regulation of Dopamine Neurotransmission and Motivated Behavior","author":"Shaw","year":"2019"},{"issue":"6","key":"10.1016\/j.bbr.2023.114497_bib71","doi-asserted-by":"crossref","first-page":"s438","DOI":"10.2741\/1074","article-title":"Arousal systems","volume":"8","author":"Jones","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bbr.2023.114497_bib72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainresbull.2022.07.014","article-title":"Role of the locus coeruleus and basal forebrain in arousal and attention","volume":"188","author":"Maness","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib73","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.108.046623","article-title":"Presynaptic \u03b17- and \u03b22-containing nicotinic acetylcholine receptors modulate excitatory amino acid release from rat prefrontal cortex nerve terminals via distinct cellular mechanisms","volume":"74","author":"Dickinson","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbr.2023.114497_bib74","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1523\/JNEUROSCI.20-12-04745.2000","article-title":"Sustained visual attention performance-associated prefrontal neuronal activity: evidence for cholinergic modulation","volume":"20","author":"Gill","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2023.114497_bib75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.conb.2014.06.004","article-title":"Neuromodulation by acetylcholine: examples from schizophrenia and depression","volume":"29","author":"Higley","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbr.2023.114497_bib76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-2236(98)01361-7","article-title":"Acetylcholine in mind: a neurotransmitter correlate of consciousness?","volume":"22","author":"Perry","year":"1999","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib77","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cercor\/bhi079","article-title":"Augmented prefrontal acetylcholine release during challenged attentional performance","volume":"16","author":"Kozak","year":"2006","journal-title":"Cereb. Cortex"},{"issue":"26","key":"10.1016\/j.bbr.2023.114497_bib78","doi-asserted-by":"crossref","first-page":"9760","DOI":"10.1523\/JNEUROSCI.1902-11.2011","article-title":"Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry","volume":"31","author":"Peters","year":"2011","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90106-U","article-title":"MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis","volume":"150","author":"Hasegawa","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib80","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.mp.4000529","article-title":"Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and \u03b12-adrenergic agonists","volume":"4","author":"Kim","year":"1999","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib81","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00213-002-1004-7","article-title":"Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats","volume":"161","author":"Nelson","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-009-1596-2","article-title":"Systemic and intrabasalis administration of the orexin-1 receptor antagonist SB-334867 disrupts attentional performance in rats","volume":"206","author":"Boschen","year":"2009","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib83","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neuroscience.2007.07.061","article-title":"Food-elicited increases in cortical acetylcholine release require orexin transmission","volume":"149","author":"Frederick-Duus","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2023.114497_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2014.10.041","article-title":"Orexin receptor activity in the basal forebrain alters performance on an olfactory discrimination task","volume":"1594","author":"Piantadosi","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2023.114497_bib85","article-title":"Basal forebrain parvalbumin neurons modulate vigilant attention","author":"Schiffino","year":"2021","journal-title":"bioRxiv"},{"issue":"51","key":"10.1016\/j.bbr.2023.114497_bib86","doi-asserted-by":"crossref","first-page":"14041","DOI":"10.1523\/JNEUROSCI.3217-07.2007","article-title":"Effects of Saporin-Induced lesions of three arousal populations on daily levels of sleep and wake","volume":"27","author":"Blanco-Centurion","year":"2007","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.bbr.2023.114497_bib87","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1046\/j.1460-9568.2002.02004.x","article-title":"The neglected constituent of the basal forebrain corticopetal projection system: GABAergic projections: cortical GABA afferents","volume":"15","author":"Sarter","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2023.114497_bib88","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0306-4522(97)00049-3","article-title":"Cortical input to the basal forebrain","volume":"79","author":"Z\u00e1borszky","year":"1997","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib89","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1749-6632.1999.tb09277.x","article-title":"Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders","volume":"877","author":"Sarter","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.bbr.2023.114497_bib90","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1523\/JNEUROSCI.20-10-03864.2000","article-title":"Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons","volume":"20","author":"Carr","year":"2000","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90641-W","article-title":"Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo","volume":"157","author":"Murase","year":"1993","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.903200202","article-title":"Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area","volume":"320","author":"Sesack","year":"1992","journal-title":"J. Comp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.bbr.2023.114497_bib93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainres.2005.05.045","article-title":"Orexin A in the nucleus accumbens stimulates feeding and locomotor activity","volume":"1050","author":"Thorpe","year":"2005","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib94","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cne.20738","article-title":"Prefrontal cortex in the rat: projections to subcortical autonomic motor and limbic centers","volume":"492","author":"Gabbott","year":"2005","journal-title":"J. Comp. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(81)91244-0","article-title":"Reciprocal connections between the lateral hypothalamus and the frontal cortex in the rat: electrophysiological and anatomical observations","volume":"213","author":"Kita","year":"1981","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbr.2023.114497_bib96","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00429-014-0869-7","article-title":"Orexin-dependent activation of layer VIb enhances cortical network activity and integration of non-specific thalamocortical inputs","volume":"220","author":"Hay","year":"2015","journal-title":"Brain Struct. Funct."},{"issue":"6","key":"10.1016\/j.bbr.2023.114497_bib97","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/schbul\/sbm088","article-title":"Schizophrenia Hypocretin (Orexin) and the thalamocortical activating system","volume":"33","author":"Lambe","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.bbr.2023.114497_bib98","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0006-3223(99)00140-7","article-title":"Role of locus coeruleus in attention and behavioral flexibility","volume":"46","author":"Aston-Jones","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114497_bib99","first-page":"521","article-title":"Electrophysiological evidence for the involvement of the locus coeruleus in alerting orienting and attending","volume":"Vol. 88","author":"Foote","year":"1991"},{"issue":"1\u20132","key":"10.1016\/j.bbr.2023.114497_bib100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01266-6","article-title":"Distribution of orexin receptor mRNA in the rat brain","volume":"438","author":"Trivedi","year":"1998","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib101","first-page":"551","article-title":"Eating, sleeping and rewarding: orexin receptors and their antagonists","volume":"9","author":"Bingham","year":"2006","journal-title":"Curr. Opin. Drug Discov. Dev."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuroscience.2010.02.002","article-title":"The role of orexin-A in food motivation reward-based feeding behavior and food-induced neuronal activation in rats","volume":"167","author":"Choi","year":"2010","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.bbr.2023.114497_bib103","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.biopsych.2009.12.035","article-title":"Orexin Signaling Via the Orexin 1 receptor mediates operant responding for food reinforcement","volume":"67","author":"Sharf","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbr.2023.114497_bib104","first-page":"8","article-title":"The role of the lateral hypothalamus and orexin in ingestive behavior: a model for the translation of past experience and sensed deficits into motivated behaviors","author":"Hurley","year":"2014","journal-title":"Front. Syst. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2023.114497_bib105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(99)01884-3","article-title":"Orexins\/hypocretins regulate drinking behaviour","volume":"842","author":"Kunii","year":"1999","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib106","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/FBP.0b013e328343d761","article-title":"Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward","volume":"22","author":"Hutcheson","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.bbr.2023.114497_bib107","first-page":"247","article-title":"A Decade of Orexin\/Hypocretin and Addiction: Where Are We Now?","volume":"Vol. 33","author":"James","year":"2016"},{"key":"10.1016\/j.bbr.2023.114497_bib108","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2016.10.018","article-title":"Orexin\/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats","volume":"1654","author":"Moorman","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2023.114497_bib109","first-page":"4","article-title":"Differential roles of Orexin receptors in the regulation of sleep\/wakefulness","author":"Mieda","year":"2013","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020360","article-title":"Pharmacogenetic modulation of Orexin neurons alters sleep\/wakefulness states in mice","volume":"6","author":"Sasaki","year":"2011","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bbr.2023.114497_bib111","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/npp.2017.158","article-title":"Effects of suvorexant, a dual Orexin\/Hypocretin receptor antagonist on impulsive behavior associated with cocaine","volume":"43","author":"Gentile","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2023.114497_bib112","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbr.2015.05.051","article-title":"Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep","volume":"291","author":"Brodnik","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib113","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espa\u00f1a","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2023.114497_bib114","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andin\u00e9","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bbr.2023.114497_bib115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1382-6689(99)00003-4","article-title":"Sex differences in dizocilpine (MK-801) neurotoxicity in rats","volume":"7","author":"Hur","year":"1999","journal-title":"Environ. Toxicol. Pharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823002152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432823002152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:40:30Z","timestamp":1759066830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432823002152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":115,"alternative-id":["S0166432823002152"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114497","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual orexin\/hypocretin receptor antagonism attenuates NMDA receptor hypofunction-induced attentional impairments in a rat model of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2023.114497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114497"}}